Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4866323
Max Phase: Preclinical
Molecular Formula: C20H27N3O8
Molecular Weight: 437.45
Molecule Type: Unknown
Associated Items:
ID: ALA4866323
Max Phase: Preclinical
Molecular Formula: C20H27N3O8
Molecular Weight: 437.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O)CCCCCOc1ccc(-c2cn([C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)nn2)cc1
Standard InChI: InChI=1S/C20H27N3O8/c24-11-15-17(27)18(28)19(29)20(31-15)23-10-14(21-22-23)12-5-7-13(8-6-12)30-9-3-1-2-4-16(25)26/h5-8,10,15,17-20,24,27-29H,1-4,9,11H2,(H,25,26)/t15-,17-,18+,19+,20+/m1/s1
Standard InChI Key: NLHQATOTLSQESN-LGKHCZOZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 437.45 | Molecular Weight (Monoisotopic): 437.1798 | AlogP: -0.06 | #Rotatable Bonds: 10 |
Polar Surface Area: 167.39 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.09 | CX Basic pKa: | CX LogP: 0.37 | CX LogD: -2.73 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.32 | Np Likeness Score: 0.21 |
1. Tomašič T, Rabbani S, Jakob RP, Reisner A, Jakopin Ž, Maier T, Ernst B, Anderluh M.. (2021) Does targeting Arg98 of FimH lead to high affinity antagonists?, 211 [PMID:33340913] [10.1016/j.ejmech.2020.113093] |
Source(1):